All lobbying filings

VANTIVE US HEALTHCARE LLC

Lobbying for VANTIVE US HEALTHCARE LLC · Medical Technology Manufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $390,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 2

HR 8319
KIDNEY Remote Monitoring Act
HR 4441
Patient Access to Innovative New Technologies Act of 2025

Lobbying activity 4

Trade (domestic/foreign)

Issues related to tariffs including issues related to Section 232 investigation of medical devices. Issues related to medical technology trade.

Medicare/Medicaid

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring. H.R. 4441 - Patient Access to Innovative New Technologies Act, Issues related to sepsis device breakthrough designation.

Health Issues

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring

Foreign Relations

Issues related to U.S. global health program priorities

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.